Inozyme Pharma Inc
INZY·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$4.01
Today
+0.0%
YTD
+0.4%
About
Founded in 2015, Inozyme Pharma, Inc. is a biotechnology company whose lead product candidate is being developed to treat ENPP1 and ABCC6 deficiencies. Operating within the US, Inozyme Pharma is headquartered in Boston, Massachusetts. The company's stock is listed on the NASDAQ GS using the INZY ticker. Use your eToro watchlist to track the price movements of INZY stock.
Price chart
Closing price history for INZY (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.38
P/S (TTM)0.00
P/B (TTM)8.11
Market cap$258.25M
Cap tierMicro-cap
Industry avg P/E-6.09
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-141.69%
ROA-78.44%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$1.68
Free cash flow$-96.55M
Total debt$46.95M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.29
Employees67
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.